53例直肠癌患者行全直肠系膜切除根治术,全组患者无手术死亡,53例患者无吻合口瘘、骶前静脉大出血等严重并发症,无尿潴留及性功能丧失。局部复发2例占3.8%(2/53),肝转移2例占3.8%(2/53),死亡3例占5.7%(3/53)。1年生存率94%(50/53),中位生存期25.2个月。全直肠系膜切除术使直肠癌患者更容易达到治愈局部控制,保留性功能和膀胱功能,提高了患者的生存率及生活质量。 53 cases of rectal cancer patients underwent total mesorectal excision radical mastectomy, all patients without surgical death, 53 patients without anastomotic fistula, presacral venous hemorrhage and other serious complications, no urine retention and loss of sexual function. Local recurrence in 2 cases accounted for 3.8% (2/53), liver metastases in 2 cases accounted for 3.8% (2/53), and death in 3 cases accounted for 5.7% (3/53). The 1-year survival rate was 94% (50/53) and the median survival time was 25.2 months. Total mesorectal excision makes it easier for patients with rectal cancer to heal local control, retention and bladder function, and improve patient survival and quality of life.